Exane Derivatives’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $452 | Hold |
14
| – | – | ﹤0.01% | 581 |
|
|
2022
Q1 | $463 | Hold |
14
| – | – | ﹤0.01% | 867 |
|
|
2021
Q4 | $596 | Hold |
14
| – | – | ﹤0.01% | 741 |
|
|
2021
Q3 | $620 | Sell |
14
-376
| -96% | -$16.7K | ﹤0.01% | 899 |
|
|
2021
Q2 | $20.5K | Hold |
390
| – | – | ﹤0.01% | 686 |
|
|
2021
Q1 | $29.2K | Hold |
390
| – | – | 0.01% | 534 |
|
|
2020
Q4 | $33.7K | Buy |
390
+384
| +6,400% | +$33.2K | 0.01% | 477 |
|
|
2020
Q3 | $367 | Hold |
6
| – | – | ﹤0.01% | 671 |
|
|
2020
Q2 | $249 | Hold |
6
| – | – | ﹤0.01% | 626 |
|
|
2020
Q1 | $172 | Hold |
6
| – | – | ﹤0.01% | 636 |
|
|
2019
Q4 | $449 | Hold |
6
| – | – | ﹤0.01% | 593 |
|
|
2019
Q3 | $842 | Hold |
6
| – | – | ﹤0.01% | 519 |
|
|
2019
Q2 | $1.1K | Hold |
6
| – | – | ﹤0.01% | 527 |
|
|
2019
Q1 | $954 | Hold |
6
| – | – | ﹤0.01% | 476 |
|
|
2018
Q4 | $575 | Hold |
6
| – | – | ﹤0.01% | 560 |
|
|
2018
Q3 | $834 | Sell |
6
-656
| -99% | -$91.2K | ﹤0.01% | 512 |
|
|
2018
Q2 | $103K | Hold |
662
| – | – | 0.02% | 304 |
|
|
2018
Q1 | $103K | Buy |
+662
| New | +$103K | 0.02% | 284 |
|